AAVantgarde Bio Srl
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) (NCT07161544) | AAVantgarde Bio Srl | 2025-09-29 |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa (NCT06591793) | AAVantgarde Bio Srl | 2024-07-02 |
| An Observational Study in Children and Adults With Stargardt Disease (NCT06591806) | AAVantgarde Bio Srl | 2024-05-01 |
Track AAVantgarde Bio Srl automatically
Every clearance here is in the API, with alerts when new ones post.